Intermezzo Finally Gains FDA Approval

Transcept Pharmaceuticals has finally secured the approval of regulators in the USA for their insomnia medication, Intermezzo. The US Food and Drug Administration (FDA) have approved Intermezzo (zolpidem) to treat insomnia characterised by middle-of-the-night waking followed by difficulty returning to sleep, which is a form of insomnia that is estimated to affect millions of adults

Continue Reading